Legal & General Group PLC Cyma Bay Therapeutics, Inc. Transaction History

Legal & General Group PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$12.63 - $24.47 $38,584 - $74,755	3,055 Added 3.67%	86,244 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $67,679 - $109,807	6,232 Added 8.1%	83,189 $1.24 Million
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $301,578 - $442,073	40,372 Added 110.35%	76,957 $842,000
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $215,119 - $350,850	36,585 New	36,585 $319,000
Q2 2022 Aug 22, 2022	SELL	$1.72 - $3.39 $12,559 - $24,753	-7,302 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $4,830 - $6,348	1,744 Added 31.38%	7,302 $23,000
Q2 2021 Aug 12, 2021	SELL	$3.94 - $4.92 $15,362 - $19,183	-3,899 Reduced 41.23%	5,558 $24,000
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $19,201 - $30,259	3,351 Added 54.88%	9,457 $54,000
Q3 2020 Nov 13, 2020	SELL	$3.32 - $7.24 $7,958 - $17,354	-2,397 Reduced 28.19%	6,106 $44,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $6,952 - $20,956	-4,931 Reduced 36.71%	8,503 $30,000
Q1 2020 May 14, 2020	SELL	$1.25 - $2.02 $3,712 - $5,999	-2,970 Reduced 18.11%	13,434 $20,000
Q4 2019 Feb 13, 2020	BUY	$1.33 - $5.93 $3,535 - $15,761	2,658 Added 19.34%	16,404 $32,000
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $19,063 - $43,042	3,151 Added 29.74%	13,746 $98,000
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $5,336 - $8,776	654 Added 6.58%	10,595 $140,000
Q2 2018 Aug 10, 2018	BUY	$10.66 - $14.38 $105,971 - $142,951	9,941 New	9,941 $134,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.